Elicio Therapeutics, Inc. — Director's Dealing 2024

Feb 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Elicio Therapeutics, Inc. (ELTX)
CIK: 0001601485
Period of Report: 2024-02-01

Reporting Person: DeMuth Peter (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-01	Stock Option (right to buy)	$4.5	A	29800	Acquired	2034-02-01	Common Stock (29800)	Direct
2024-02-01	Stock Option (right to buy)	$4.5	A	342	Acquired	2034-02-01	Common Stock (342)	Direct

Footnotes

F1: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

F2: The stock options vested in full on February 1, 2024.